Mar 09, 2026
- Sustainability
- Corporate
Chugai Selected for the “KENKO Investment for Health” for the Third Consecutive Year
The KENKO Investment for Health is a program jointly administered by METI and TSE to promote health management initiatives among listed enterprises. The program selects companies that view employee health management from a management perspective and engage in strategic initiatives, and introduces them to investors who place importance on the enhancement of corporate value from a long-term perspective. Specifically, one enterprise per industry is selected in principle from among listed enterprises ranked within the top 500 applicants for the Outstanding Organizations of KENKO Investment for Health (Large Enterprise Category).
Based on the basic philosophy that human resources are an invaluable asset that drives corporate growth and development, Chugai positions “employee well-being” as one of its material issues for creating shared value through the realization of advanced and sustainable patient-centric healthcare. The Company regards employee health as the foundation of all business activities. To enable the people, who are key to realizing its growth strategy “TOP I 2030,” to work proactively and autonomously with a sense of fulfillment and purpose, Chugai continuously implements systems and initiatives that contribute to the promotion of physical and mental health.
Chugai Pharmaceutical will continue to strive to create a workplace environment and organizational culture in which all employees can work energetically and thrive.
[Reference]
Health and Productivity Management:
https://www.chugai-pharm.co.jp/english/sustainability/healthmanagement/index.html
External Evaluations:
https://www.chugai-pharm.co.jp/english/sustainability/evaluation/index.html
Contact:
- For Media
- Chugai Pharmaceutical Co., Ltd.
- Media Relations Group, Corporate Communications Dept.,
- Naoki Kouzai
- Tel: +81-3-3273-0881
- E-mail: pr@chugai-pharm.co.jp
- For Investors
- Chugai Pharmaceutical Co., Ltd.
- Investor Relations Group, Corporate Communications Dept.,
- Takayuki Sakurai
- Tel: +81-3-3273-0554
- E-mail: ir@chugai-pharm.co.jp